Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple-negative Breast Cancer
Interventions: DRUG: Chidamide combined with Cisplatin
Sponsor: Fudan University